CANY
AHCO icon

Caxton Associates (New York)’s AdaptHealth AHCO Stock Holding History

Caxton Associates (New York)’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-38,334
Closed -$383K – 518
2024
Q2 		$383K Buy
+38,334
New +$390K 0.01% 370

Other funds holding AHCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Caxton Associates (New York)'s AHCO Position: Q3 2024 in Review

Caxton Associates (New York) sold out of AdaptHealth (AHCO) in Q3 2024, closing a stake of 38,334 shares — an estimated $383K sold.

Caxton Associates (New York) first reported a position in AHCO in Q2 2024 and held it in 1 quarter. The position peaked at $383K in Q2 2024. 217 funds tracked by Wall St. Rank hold AHCO as of Q3 2024.

  • Caxton Associates (New York) reported no remaining AdaptHealth position as of Q3 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 38,334 AdaptHealth shares in Q3 2024, an estimated $383K.
  • Caxton Associates (New York) first reported a position in AdaptHealth in Q2 2024 and held it in 1 quarter.
  • Caxton Associates (New York)'s AdaptHealth position peaked at $383K in Q2 2024.
  • 217 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2024.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.